POSTERS

THERAPEUTICS/PRECLINICAL STUDIES
001	Efficacy of Mogamulizumab in Combination Therapy for Relapsed or Refractory Sézary Syndrome | Jordan Pilkington, BA
002	Evaluation of Long-term Responses of Use of Chlormethine in Mycosis Fungoides | Silvia Alberti-Violetti, MD, PhD
003	A Case Report on the Utilization of Excimer 308 nm Lamp Therapy in Treatment of Early-stage Mycosis Fungoides | Christina Asare, BS
004	Mogamulizumab-induced Cardiotoxicity in Cutaneous T-Cell Lymphoma | Megan Trager, MD, MS
005	Surgical Treatment for Cutaneous B-cell Lymphoma | Thais Buffo, MD
006	Moga-stop Study: Outcome  of Patients with Sézary Syndrome Treated with Mogamulizumab, after Treatment Discontinuation (Progression Excluded) | Martine Bagot, MD, PhD
007	Evolution of the First Cohort of Patients with Mycosis Fungoides and Sézary Syndrome Undergoing Allogeneic Hematopoietic Progenitor Cell Transplantation in Argentina | Paula Enz, MD
008	Radiation Therapy Combined with Hematopoietic Stem Cell Transplantation for T-Cell Lymphomas | Savita Dandapani, MD, PhD
009	Chlormethine Gel as Active and as Maintenance Treatment in Mycosis Fungoides Patients Stages IA IIB | Marios Koumourtzis, MD, MSc
010	Trial in Progress: EORTC 1820 MOGAT – Mogamulizumab Plus Total Skin Electron Beam Therapy in Stage IB-IIB Cutaneous T-Cell Lymphoma | Pablo L. Ortiz-Romero, MD, PhD
011	Intralesional Rituximab Therapy for the Treatment of Primary Cutaneous B-Cell Lymphoma: A Small Case Series | Jori Hardin, MD
CHALLENGING CASES OF CUTANEOUS LYMPHOMAS
012	Concurrent Papular and Dyshidrotic Mycosis Fungoides in a Black Patient | Jori Hardin, MD
013	Omental-predominant Subcutaneous Panniculitis-like T-Cell Lymphoma Simulating Peritoneal Carcinomatosis | Ben J. Friedman, MD
014	The Development of Two Clonally and Histologically Distinct Subtypes of Extranodal B-Cell Lymphomas in the Brain and Skin in One Individual | Jenna Mandel, BS
015	Widespread Visceral Metastasis in a Large Cell Transformed Mycosis Fungoides Patient in a Clinical Complete Cutaneous Response | Jennifer A. DeSimone, MD
016	Lymphomatoid Papulosis with an Unusually Prominent B-Cell Population and Features of T Follicular Helper Phenotype | John S. Runge, MD, PhD
017	Systemic Anaplastic Large Cell Lymphoma with Unbalanced DUSP22 Gene Rearrangement Exclusively Involving the Skin | John S. Runge, MD, PhD
018	Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective: Case Report | Paula Enz, MD
019	Epstein-Barr Virus Positive Mucocutaneous Ulcer and Atypical Mycobacteria Infection in an Immunosuppressed Patient Associated with Methotrexate | Paula Enz, MD
020	Unexplained Persistent Transaminitis in a Patient with Sézary Syndrome | Caitlyn Myrdal, MD
021	Mycosis Fungoides Presenting as Dermatomyositis: A Diagnostic Challenge | Jacqueline M. Junkins-Hopkins, MD
022	From Atopy to Sézary Syndrome and Back Again: A Case Report of Sézary Syndrome Diagnosis Secondary to Dupilumab Use with Spontaneous Improvement after Dupilumab Cessation | Martha Lodyga, MD
023	Mycosis Fungoides - A Story of Non-pruritic Rash Unveiling T-Cell Non-Hodgkin's Lymphoma | Neil Vuppala, BA
024	The Spectrum of CD8+ Cutaneous T-Cell Lymphomas: Clinical, Histologic, and Phenotypic Variants | Madisen Swallow, MS
025	Poikilodermatous Mycosis Fungoides in an 18-year-old Filipino Female | Cybill Dianne C. Uy, MD
026	New Frontier: A Complex Case of a 65-year-old Filipino Male with Sézary Syndrome  | Precious U. Imam, MD, DPDS
027	Diffuse Large B-Cell Lymphoma of the Skin with Colonization of a Haemangioma Mimicking Intravascular Large B-Cell Lymphoma Benjamin Ho, MBBS, MRCP
028	Tumor Stage Mycosis Fungoides in a 5-year-old | Rishabh Lohray, BS
029	Mycosis Fungoides in Pregnancy: Disease Activity and Outcomes | Rishabh Lohray, BS (Classification/Epidemiology/Prognostic Factors)
030	Primary Cutaneous Epidermotropic, Cytotoxic, ALK+ T-Cell Lymphoma: Appraisal of a Discrete Pattern of Disease | Italo Francesco Aromolo, MD
CLASSIFICATION/EPIDEMIOLOGY/PROGNOSTIC FACTORS
031	GATA3 Expression in CD4 Small/Medium-sized Pleomorphic Lymphoproliferative Disorder: Evaluation of T Follicular Helper Subsets | Italo Francesco Aromolo, MD
032	Is Small-plaque Parapsoriasis the Right Term? Clinico-pathological Evaluation of 30 Cases | Italo Francesco Aromolo, MD
033	Cutaneous T-Cell Lymphoma and Dupilumab Use: A Retrospective Matched Cohort Study of Clinical Characteristics and Treatment Outcomes | Robert Stuver, MD
034	Updates on CTCL Diagnostic and Therapeutic Trends Amidst the COVID-19 Pandemic: Insights from an Italian Referral Center | Gabriele Roccuzzo, MD
035	Preliminary Insights on Different Erythroderma Morphological Features: A Prospective Validation Study | Gabriele Roccuzzo, MD
036	Changes to Mycosis Fungoides and Sézary Syndrome Clinical Trials after the 2011 Tri-societies Guidelines | Simon J. Gunter, MPhil
037	Cutaneous Lymphoproliferative Disorders after COVID-19 Vaccination: Analysis of 50 International Cases | Emily R. Gordon, BA
038	Passing Notes: Designing a Standardized CTCL Note Template Based on ISCL Expert Consensus | Emily R. Gordon, BA
039	From Pause to Progression: Lessons for CTCL Maintenance Therapy from the COVID-19 Pandemic | Emily R. Gordon, BA
040	Visceral Involvement in Cutaneous T-Cell Lymphoma: Clinical Characteristics  and Outcomes | Sima Rozati, MD, PhD
041	Mogamulizumab-associated Myasthenia Gravis: A Patient Report | Sima Rozati, MD, PhD (Challenging Cases of Cutaneous Lymphomas)
042	Presentation and Outcomes of Cutaneous T-Cell Lymphoma Following the Use of Dupilumab Compared to Other Biologic Therapies | Sima Rozati, MD, PhD (Biologic Insights)
043	Outcomes with Sequencing of Romidepsin Followed by Mogamulizumab for the Treatment of Cutaneous T-Cell Lymphomas | Emily R. Gordon, BA (Biologic Insights)
044	Cutaneous T-Cell Lymphoma Clinical Trial Enrollment and Reporting Demographics: A Systematic Review | Leore Lavin, MS
045	US FDA Reports of Cutaneous T-Cell Lymphoma and Lymphoma-related Events Associated with Dupilumab | Leore Lavin, MS
046	Clinicoprognostic Implications of Blood Eosinophilia and Tissue Eosinophil Infiltration in Mycosis Fungoides: A Retrospective Cohort Study | Woo Jin Lee, MD, PhD
047	Mycosis Fungoides and Associated Malignancies in a Dutch Nationwide Retrospective Cohort Study | Rosanne Ottevanger, MD
048	Risk of Systemic Lymphoma in Patients with Cutaneous CD30+ Lymphoproliferative Disorder: A Single Center Retrospective Analysis | Michi Shinohara, MD
049	Histopathological Features of Mycosis Fungoides in a Cohort of Asian Children | Mark Jean-Aan Koh, MBBS
050	Chemical Exposures and Demographic Associations in Cutaneous T-Cell Lymphoma: A Large Single Institution Physician Validated Cohort Study | Yanzhen (Janet) Pang, BS
051	Clinicopathological Features and Mortality in Patients Folliculotropic Mycosis Fungoides: A Retrospective Analysis | Kelly Meza, MD
052	Granulomatous Mycosis Fungoides: A Retrospective Cohort Study | Samruddhi Arkatkar, BS
053	Mogamulizumab for the Treatment of Cutaneous T-Cell Lymphoma: Characterization of Patients Achieving Skin Response | Rachel E. Christensen, MD
054	Overall and Cause-specific Mortality Among Patients with Cutaneous T-Cell Lymphoma from the United States | Lauren Shea, MD
TUMOR MICROENVIRONMENT
055	Prognostic Factors Based on the Tumor Microenvironment In Primary Cutaneous B-Cell Lymphoma: Retrospective Study of 216 Biopsies | Gabor Dobos, MD, PhD
PATHOGENESIS/BIOMARKERS
056	The Diagnostic Value of CD4+CD7-CD26- (Double-negative) T Cells from Flow Cytometry in the Diagnosis and Follow up of Mycosis Fungoides and Sézary Syndrome: A Prospective Study | Gabor Dobos, MD, PhD
057	New Marker for the Diagnosis of Mycosis Fungoides | Ekaterina Dunaeva, MD
058	The Use of Flow Cytometry of Skin Lesions as a Complementary Diagnostic Method for Cutaneous T-Cell Lymphoma | Rodrigo Cesar Davanco
TRIALS IN PROGRESS
059	A Study of DR-01 in Subjects with Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas | Kimberley Dilley, MD, MPH
060	Phase 1 Pharmacodynamic and Pharmacokinetic Study of the Geranylgeranyltransferase I Inhibitor PTX-100 in Patients with Advanced Malignancies with an Expansion Cohort Recruiting T-Cell Lymphoma Patients | H. Miles Prince AM, MBBS (Hons), MD
061	Lymphatic Delivery of Pembrolizumab to Tumor Draining  Lymph Nodes in Relapsed or Refractory Mycosis Fungoides | Russell Ross, PhD
062	A Phase 1a/1b Trial of ST-001, a Fenretinide (4-HPR) Phospholipid Suspension for 4-hour Intravenous Infusion, in Relapsed/Refractory T-Cell Non-Hodgkin’s Lymphoma (NCT04234048) | Oleg E. Akilov, MD, PhD
LEADING-EDGE RESEARCH AND FUTURE DIRECTIONS OF CUTANEOUS LYMPHOMAS
063	The Role of PET/CT in the Staging of Mycosis Fungoides and Sézary Syndrome | Jade Cury-Martins, MD, PhD
MULTIPLE/MULTIPLE FOCUS AREAS
064	Subcutaneous Panniculitis-like T-Cell Lymphoma: A Diagnostic Challenge | Juliana Yumi Massuda Serrano, MD, MSc (Challenging Cases of Cutaneous Lymphomas)
065	If Purpuric Lesions, Think of Mycosis Fungoides | Juliana Yumi Massuda Serrano, MD, MSc (Challenging Cases of Cutaneous Lymphomas)
066	Exuberant Primary Cutaneous Marginal Zone B-Cell Lymphoma with Orbital Invasion | Juliana Yumi Massuda Serrano, MD, MSc (Challenging Cases of Cutaneous Lymphomas)
067	Ichthyosiform Lesions: Think “Lymphomatously” | Juliana Yumi Massuda Serrano, MD, MSc (Challenging Cases of Cutaneous Lymphomas)
068	Assessment of Infection Profile and Incidence of Other Malignant Neoplasms in Patients with Mycosis Fungoides and Sézary Syndrome | Juliana Yumi Massuda Serrano, MD, MSc (Quality of Life/Patient-Reported Outcomes)
069	Unexpected Evolution with Psoriasis and Atopic Dermatitis Treatments: The Need to Consider a Lymphoma | Juliana Yumi Massuda Serrano, MD, MSc (Quality of Life/Patient-Reported Outcomes)
070	Unusual Connection: Are There Links Between Pachydermatous Eosinophilic Dermatitis and Granulomatous Slack Skin? | Elisa Nunes Secamilli, MD (Challenging Cases of Cutaneous Lymphomas)
071	Nodular Skin Infiltrations – Pseudolymphoma vs. Lymphomatous Infiltration? | Elisa Nunes Secamilli, MD (Challenging Cases of Cutaneous Lymphomas)
072	Treatment of Bartonella Henselae Infection as a Modifying Factor of the Immune Response in Sézary Syndrome | Elisa Nunes Secamilli, MD (Challenging Cases of Cutaneous Lymphomas)
073	Clinical and Histological Differences Between Pediatric Pityriasis Lichenoides and Hypopigmented Mycosis Fungoides| Elisa Nunes Secamilli, MD (Challenging Cases of Cutaneous Lymphomas)
074	Incidence of Bartonella Sp. Bacteremia on Patients with Cutaneous T-Cell Lymphomas and Healthy Subjects: A Pilot Study | Elisa Nunes Secamilli, MD (Pathogenesis/Biomarkers)